Φορτώνει......
Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma
Evidence supporting rechallenge in patients responding to first exposure to trabectedin is limited. We report on a 39-year-old woman with advanced high-grade undifferentiated sarcoma (US) retreated twice with trabectedin after first response. The patient presented in June 2006 with an abdominal mass...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Anticancer Drugs |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010279/ https://ncbi.nlm.nih.gov/pubmed/27348763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000398 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|